TeSR™-AOF: Designing a Product for the Future
Hear how TeSR™-AOF ticks all the boxes for successful quality and risk assessment on your path to the clinic. Scientist Kimberly Snyder discusses TeSR™-AOF’s optimized performance compared to low protein media and Lynn Csontos, Senior Director for Quality Assurance and Regulatory Affairs, explains its enhanced safety profile.
Publish Date: July 28, 2021
Views: 0
Related Multimedia
-
TeSR™-AOF Data Overview
Publish Date: January 18, 2021 -
Nature Research Round Table: hPSC Lines for Cell Therapies - Panel Discussion
Publish Date: November 01, 2019 -
Lost in Translation - Moving Your Research to Clinical Trials
Publish Date: May 14, 2021
Explore Our Products
-
cGMP, animal origin-free, stabilized, feeder-free maintenance medium for human ES and iPS cells
